192 related articles for article (PubMed ID: 23087187)
21. Mef2c deletion in osteocytes results in increased bone mass.
Kramer I; Baertschi S; Halleux C; Keller H; Kneissel M
J Bone Miner Res; 2012 Feb; 27(2):360-73. PubMed ID: 22161640
[TBL] [Abstract][Full Text] [Related]
22. B Cell Development sans B Cell Receptor Responsiveness Due to Unfolded Protein Response-Triggered Mef2c Protein Degradation.
Chen YT; Su YC; Kung JT
J Immunol; 2018 Nov; 201(10):2885-2898. PubMed ID: 30305329
[TBL] [Abstract][Full Text] [Related]
23. A p38 MAPK-MEF2C pathway regulates B-cell proliferation.
Khiem D; Cyster JG; Schwarz JJ; Black BL
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17067-72. PubMed ID: 18955699
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition.
Badodi S; Baruffaldi F; Ganassi M; Battini R; Molinari S
Cell Cycle; 2015; 14(10):1517-28. PubMed ID: 25789873
[TBL] [Abstract][Full Text] [Related]
25. MEF2C Interacts With c-FOS in PTH-Stimulated Mmp13 Gene Expression in Osteoblastic Cells.
Nakatani T; Partridge NC
Endocrinology; 2017 Nov; 158(11):3778-3791. PubMed ID: 28973134
[TBL] [Abstract][Full Text] [Related]
26. Myocyte enhancer factor 2C in hematopoiesis and leukemia.
Canté-Barrett K; Pieters R; Meijerink JP
Oncogene; 2014 Jan; 33(4):403-10. PubMed ID: 23435431
[TBL] [Abstract][Full Text] [Related]
27. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
[TBL] [Abstract][Full Text] [Related]
28. MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription.
Zhang H; Liu W; Wang Z; Meng L; Wang Y; Yan H; Li L
Tumori; 2018 Jun; 104(3):221-231. PubMed ID: 29714661
[TBL] [Abstract][Full Text] [Related]
29. MEF2C promotes M1 macrophage polarization and Th1 responses.
Zhao X; Di Q; Liu H; Quan J; Ling J; Zhao Z; Xiao Y; Wu H; Wu Z; Song W; An H; Chen W
Cell Mol Immunol; 2022 Apr; 19(4):540-553. PubMed ID: 35194174
[TBL] [Abstract][Full Text] [Related]
30. Conditional Loss of MEF2C Expression in Osteoclasts Leads to a Sex-Specific Osteopenic Phenotype.
Maisuria R; Norton A; Shao C; Bradley EW; Mansky K
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628864
[TBL] [Abstract][Full Text] [Related]
31. Myocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralization.
Stephens AS; Stephens SR; Hobbs C; Hutmacher DW; Bacic-Welsh D; Woodruff MA; Morrison NA
J Biol Chem; 2011 Aug; 286(34):30071-86. PubMed ID: 21652706
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
33. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
Maiti D; Xu Z; Duh EJ
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
[TBL] [Abstract][Full Text] [Related]
35. The in vitro derivation of phenotypically mature and diverse B cells from immature spleen and bone marrow precursors.
Roundy KM; Jacobson AC; Weis JJ; Weis JH
Eur J Immunol; 2010 Apr; 40(4):1139-49. PubMed ID: 20077404
[TBL] [Abstract][Full Text] [Related]
36. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
Dodou E; Xu SM; Black BL
Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of the transcription factor Mef2c during retinal degeneration in Rpe65-/- mice.
Escher P; Schorderet DF; Cottet S
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5933-40. PubMed ID: 21715356
[TBL] [Abstract][Full Text] [Related]
38. RNA Binding Protein, HuR, Regulates
Zhou A; Shi G; Kang GJ; Xie A; Liu H; Jiang N; Liu M; Jeong EM; Dudley SC
J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29678826
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.
Debnath I; Roundy KM; Weis JJ; Weis JH
Mol Immunol; 2007 Mar; 44(9):2388-99. PubMed ID: 17140663
[TBL] [Abstract][Full Text] [Related]
40. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
